Abstract:Neurotransmitters are an important category of substances used inside the nervous system, whose detection with biosensors has been seriously addressed in the last decades. Dopamine, a neurotransmitter from the catecholamine family, was recently discovered to have implications for cardiac arrest or muscle contractions. In addition to having many other neuro-psychiatric implications, dopamine can be detected in blood, urine, and sweat. This review highlights the importance of biosensors as influential tools for dopamine recognition. The first part of this article is related to an introduction to biosensors for neurotransmitters, with a focus on dopamine. The regular methods in their detection are expensive and require high expertise personnel. A major direction of evolution of these biosensors has expanded with the integration of active biological materials suitable for molecular recognition near electronic devices. Secondly, for dopamine in particular, the miniaturized biosensors offer excellent sensitivity and specificity and offer cheaper detection than conventional spectrometry, while their linear detection ranges from the last years fall exactly on the clinical intervals. Thirdly, the applications of novel nanomaterials and biomaterials to these biosensors are discussed. Older generations, metabolism-based or enzymatic biosensors, could not detect concentrations below the micro-molar range. But new generations of biosensors combine aptamer receptors and organic electrochemical transistors, OECTs, as transducers. They have pushed the detection limit to the pico-molar and even femto-molar ranges, which fully correspond to the usual ranges of clinical detection of human dopamine in body humors that cover 0.1 ÷ 10 nM. In addition, if ten years ago the use of natural dopamine receptors on cell membranes seemed impossible for biosensors, the actual technology allows co-integrate transistors and vesicles with natural receptors of dopamine, like G protein-coupled receptors. The technology is still complicated, but the uni-molecular detection selectivity is promising.

Microelectronics-based biosensors dedicated to the detection of neurotransmitters: a review

Enzymatic Electrochemical Biosensors for Neurotransmitters Detection: Recent Achievements and Trends

Monitoring the Electrochemical Responses of Neurotransmitters Through Localized Surface Plasmon Resonance Using Nanohole Array.

Real-Time Monitoring of Neurotransmitters in the Brain of Living Animals

Advancements in Brain Research: The In Vivo/In Vitro Electrochemical Detection of Neurochemicals

Studies of Selective Ion-Sensitive Microelectrode Technique for the Detection of Neurotransmitter in Vivo

Breaking Barriers: Exploring Neurotransmitters through In Vivo vs. In Vitro Rivalry

Paper-Based Electrochemical Biosensors for Point-of-Care Testing of Neurotransmitters

New Insights into the Biosensing of Parkinson's Disease Biomarkers: A Concise Review

Advanced Nanomaterials-Based Electrochemical Biosensors for Catecholamines Detection: Challenges and Trends

Advances in micro-nano biosensing platforms for intracellular electrophysiology

From Enzymatic Dopamine Biosensors to OECT Biosensors of Dopamine

Recent advances of electrochemical and optical point-of-care biosensors for detecting neurotransmitter serotonin biomarkers

Electrochemical Biosensing of Dopamine Neurotransmitter: A Review

Electrochemical biosensors in early detection of Parkinson disease

Advances In Electrochemical Biosensors For In Vivo Analysis

Significance of an Electrochemical Sensor and Nanocomposites: Toward the Electrocatalytic Detection of Neurotransmitters and Their Importance within the Physiological System

Application of Advanced Biosensors in Nervous System Diseases

Biosensing: The best alternative for conventional methods in detection of Alzheimer's disease biomarkers

Recent Advances In Detection Methods For Neurotransmitters

Recent advances in electronic devices for monitoring and modulation of brain